Literature DB >> 16354698

Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species.

Valentina Evdokimova1, Peter Ruzanov, Michael S Anglesio, Alexey V Sorokin, Lev P Ovchinnikov, Jonathan Buckley, Timothy J Triche, Nahum Sonenberg, Poul H B Sorensen.   

Abstract

YB-1 is a broad-specificity RNA-binding protein that is involved in regulation of mRNA transcription, splicing, translation, and stability. In both germinal and somatic cells, YB-1 and related proteins are major components of translationally inactive messenger ribonucleoprotein particles (mRNPs) and are mainly responsible for storage of mRNAs in a silent state. However, mechanisms regulating the repressor activity of YB-1 are not well understood. Here we demonstrate that association of YB-1 with the capped 5' terminus of the mRNA is regulated via phosphorylation by the serine/threonine protein kinase Akt. In contrast to its nonphosphorylated form, phosphorylated YB-1 fails to inhibit cap-dependent but not internal ribosome entry site-dependent translation of a reporter mRNA in vitro. We also show that similar to YB-1, Akt is associated with inactive mRNPs and that activated Akt may relieve translational repression of the YB-1-bound mRNAs. Using Affymetrix microarrays, we found that many of the YB-1-associated messages encode stress- and growth-related proteins, raising the intriguing possibility that Akt-mediated YB-1 phosphorylation could, in part, increase production of proteins regulating cell proliferation, oncogenic transformation, and stress response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16354698      PMCID: PMC1317623          DOI: 10.1128/MCB.26.1.277-292.2006

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

Review 1.  The pleiotropic functions of the Y-box-binding protein, YB-1.

Authors:  Kimitoshi Kohno; Hiroto Izumi; Takeshi Uchiumi; Megumi Ashizuka; Michihiko Kuwano
Journal:  Bioessays       Date:  2003-07       Impact factor: 4.345

2.  Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes.

Authors:  Vinagolu K Rajasekhar; Agnes Viale; Nicholas D Socci; Martin Wiedmann; Xiaoyi Hu; Eric C Holland
Journal:  Mol Cell       Date:  2003-10       Impact factor: 17.970

Review 3.  Masking of mRNA by Y-box proteins.

Authors:  J Sommerville; M Ladomery
Journal:  FASEB J       Date:  1996-03       Impact factor: 5.191

4.  Overexpression in COS cells of p50, the major core protein associated with mRNA, results in translation inhibition.

Authors:  E K Davydova; V M Evdokimova; L P Ovchinnikov; J W Hershey
Journal:  Nucleic Acids Res       Date:  1997-07-15       Impact factor: 16.971

5.  Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway.

Authors:  A Khwaja; P Rodriguez-Viciana; S Wennström; P H Warne; J Downward
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

6.  The major protein of messenger ribonucleoprotein particles in somatic cells is a member of the Y-box binding transcription factor family.

Authors:  V M Evdokimova; C L Wei; A S Sitikov; P N Simonenko; O A Lazarev; K S Vasilenko; V A Ustinov; J W Hershey; L P Ovchinnikov
Journal:  J Biol Chem       Date:  1995-02-17       Impact factor: 5.157

Review 7.  Structural and functional properties of the evolutionarily ancient Y-box family of nucleic acid binding proteins.

Authors:  A P Wolffe
Journal:  Bioessays       Date:  1994-04       Impact factor: 4.345

8.  The mammalian target of rapamycin phosphorylates sites having a (Ser/Thr)-Pro motif and is activated by antibodies to a region near its COOH terminus.

Authors:  G J Brunn; P Fadden; T A Haystead; J C Lawrence
Journal:  J Biol Chem       Date:  1997-12-19       Impact factor: 5.157

9.  A multi-protein complex containing cold shock domain (Y-box) and polypyrimidine tract binding proteins forms on the vascular endothelial growth factor mRNA. Potential role in mRNA stabilization.

Authors:  Leeanne S Coles; M Antonetta Bartley; Andrew Bert; Julie Hunter; Steven Polyak; Peter Diamond; Mathew A Vadas; Gregory J Goodall
Journal:  Eur J Biochem       Date:  2004-02

10.  Y box-binding protein 1 induces resistance to oncogenic transformation by the phosphatidylinositol 3-kinase pathway.

Authors:  Andreas G Bader; Katherine A Felts; Ning Jiang; Hwai Wen Chang; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-06       Impact factor: 11.205

View more
  107 in total

1.  Aberrant Expression of proPTPRN2 in Cancer Cells Confers Resistance to Apoptosis.

Authors:  Alexey V Sorokin; Binoj C Nair; Yongkun Wei; Kathryn E Aziz; Valentina Evdokimova; Mien-Chie Hung; Junjie Chen
Journal:  Cancer Res       Date:  2015-04-15       Impact factor: 12.701

2.  The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapy.

Authors:  Suhu Liu; Anna E Marneth; Gabriela Alexe; Sarah R Walker; Helen I Gandler; Darwin Q Ye; Katherine Labella; Radhika Mathur; Patricia A Toniolo; Michelle Tillgren; Prafulla C Gokhale; David Barbie; Ann Mullally; Kimberly Stegmaier; David A Frank
Journal:  Blood Adv       Date:  2018-12-11

3.  Copb1-facilitated axonal transport and translation of kappa opioid-receptor mRNA.

Authors:  Jing Bi; Nien-Pei Tsai; Hsin-Yi Lu; Horace H Loh; Li-Na Wei
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-13       Impact factor: 11.205

4.  General RNA-binding proteins have a function in poly(A)-binding protein-dependent translation.

Authors:  Yuri V Svitkin; Valentina M Evdokimova; Ann Brasey; Tatyana V Pestova; Daniel Fantus; Akiko Yanagiya; Hiroaki Imataka; Maxim A Skabkin; Lev P Ovchinnikov; William C Merrick; Nahum Sonenberg
Journal:  EMBO J       Date:  2008-12-11       Impact factor: 11.598

5.  YB-1 transcription in the postnatal brain is regulated by a bHLH transcription factor Math2 through an E-box sequence in the 5'-UTR of the gene.

Authors:  Sachiyo Ohashi; Reiko Fukumura; Takashi Higuchi; Shunsuke Kobayashi
Journal:  Mol Cell Biochem       Date:  2009-02-19       Impact factor: 3.396

6.  Akt2 regulation of Cdc2-like kinases (Clk/Sty), serine/arginine-rich (SR) protein phosphorylation, and insulin-induced alternative splicing of PKCbetaII messenger ribonucleic acid.

Authors:  Kun Jiang; Niketa A Patel; James E Watson; Hercules Apostolatos; Eden Kleiman; Olivia Hanson; Masatoshi Hagiwara; Denise R Cooper
Journal:  Endocrinology       Date:  2008-12-30       Impact factor: 4.736

7.  YB-1 acts as a ligand for Notch-3 receptors and modulates receptor activation.

Authors:  Thomas Rauen; Ute Raffetseder; Björn C Frye; Sonja Djudjaj; Philipp J T Mühlenberg; Frank Eitner; Urban Lendahl; Jürgen Bernhagen; Steven Dooley; Peter R Mertens
Journal:  J Biol Chem       Date:  2009-07-29       Impact factor: 5.157

8.  Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells.

Authors:  Anna L Stratford; Christopher J Fry; Curtis Desilets; Alastair H Davies; Yong Y Cho; Yvonne Li; Zigang Dong; Isabelle M Berquin; Philippe P Roux; Sandra E Dunn
Journal:  Breast Cancer Res       Date:  2008-11-27       Impact factor: 6.466

9.  Y-box protein-1 is actively secreted through a non-classical pathway and acts as an extracellular mitogen.

Authors:  Björn C Frye; Sarah Halfter; Sonja Djudjaj; Philipp Muehlenberg; Susanne Weber; Ute Raffetseder; Abdelaziz En-Nia; Hanna Knott; Jens M Baron; Steven Dooley; Jürgen Bernhagen; Peter R Mertens
Journal:  EMBO Rep       Date:  2009-05-29       Impact factor: 8.807

10.  Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer.

Authors:  Edgar Dahl; Abdelaziz En-Nia; Frank Wiesmann; Renate Krings; Sonja Djudjaj; Elisabeth Breuer; Thomas Fuchs; Peter J Wild; Arndt Hartmann; Sandra E Dunn; Peter R Mertens
Journal:  BMC Cancer       Date:  2009-11-24       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.